[INCREASE IN THE NUMBER OF INFANTS WITH KOCH PHENOMENON AFTER BCG VACCINATION]

Kekkaku : [Tuberculosis]
|October 20, 2015
PubMed

Insights

The timing of BCG vaccination was changed, leading to a doubling of infants diagnosed with latent tuberculosis infection (LTBI), likely due to Koch phenomenon. Further analysis is needed to confirm this trend.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Tuberculosis epidemiology

Context:

  • BCG vaccination is a primary method for preventing tuberculosis in infants.
  • Changes in vaccination schedules can impact disease incidence and related phenomena.
  • The Koch phenomenon, a localized inflammatory reaction, can occur post-BCG vaccination.

Purpose:

  • To evaluate the impact of a modified BCG vaccination schedule on the incidence of Koch phenomenon in infants.
  • To analyze trends in latent tuberculosis infection (LTBI) and active tuberculosis diagnoses in infants before and after the vaccination timing change.

Summary:

  • Analysis of Japanese tuberculosis surveillance data from infants (≤1 year) before and after May 2012 revealed no increase in active tuberculosis cases.
  • A significant doubling of latent tuberculosis infection (LTBI) diagnoses was observed, from 45 to 90 cases.
  • This increase in LTBI is presumed to be associated with a higher incidence of Koch phenomenon following the altered BCG vaccination timing.

Impact:

  • The findings suggest a potential increase in Koch phenomenon among infants after the BCG vaccination schedule modification.
  • Highlights the need for further investigation into the relationship between vaccination timing and post-vaccination inflammatory responses.
  • Informs public health strategies regarding infant tuberculosis prevention and vaccination protocols.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
34
Vaccinations01:51

Vaccinations

Overview
53.9K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
37